Altering the propensity for density: the benefits and risks of selective estrogen receptor modulators.
Victor G
VG
Vogel
D000328:Adult; D000368:Aged; D015519:Bone Density / Q000187:drug effects*; D001943:Breast Neoplasms / Q000517:prevention & control; D005260:Female; D006801:Humans; D007211:Indoles / Q000008:administration & dosage / Q000009:adverse effects; D008875:Middle Aged; D015663:Osteoporosis, Postmenopausal / Q000517:prevention & control; D017698:Postmenopause; D020849:Raloxifene Hydrochloride / Q000008:administration & dosage / Q000009:adverse effects; D016032:Randomized Controlled Trials as Topic; D020845:Selective Estrogen Receptor Modulators / Q000008:administration & dosage*; D013629:Tamoxifen / Q000008:administration & dosage / Q000009:adverse effects
D007211:Indoles; D020845:Selective Estrogen Receptor Modulators; D013629:Tamoxifen; D020849:Raloxifene Hydrochloride; C447119:bazedoxifene